Dr. Anthony Nicholas
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 191
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: University of Texas Medical Branch at Galveston
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
TN license 74843 · AL license 18697
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Memorial Hospital Memphis, TN
- Regional One Health Memphis, TN
Medical groups
- Ut Regional One Physicians Inc (324 clinicians)
- Ut Medical Group Inc (96 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 191
- Services billed
- 462
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 74 | 74 |
| Established patient office or other outpatient visit, 40-54 minutes | 62 | 61 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 43 | 15 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | 13 |
| New patient office or other outpatient visit, 60-74 minutes | 24 | 24 |
| Established patient office or other outpatient visit, 20-29 minutes | 12 | 12 |
| Hospital discharge day management, 30 minutes or less | 11 | 11 |
| New patient office or other outpatient visit, 45-59 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Memphis, TN | 284 |
| Clonazepam Other prescribers in Memphis, TN | 206 |
| Primidone Other prescribers in Memphis, TN | 102 |
| Rasagiline Mesylate | 79 |
| Gabapentin Other prescribers in Memphis, TN | 70 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Memphis, TN | 69 |
| Pramipexole Dihydrochloride (pramipexole di-hcl) Other prescribers in Memphis, TN | 64 |
| Donepezil Hcl Other prescribers in Memphis, TN | 50 |
| Neupro (rotigotine) | 35 |
| Nuplazid (pimavanserin tartrate) | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $25.48 in total to this clinician.
| Amneal Pharmaceuticals LLC | $25.48 |
|---|
| Food and Beverage | $25.48 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 2 companies. The companies reported $103,098 in research payments for these studies, mostly to the institutions running them.
- Phase II study in early stage Parkinson s Disease Patients
Roche Tcrc, Inc. - Open-label Trial in Parkinson s Disease (PD) (TEMPO-4)
AbbVie Inc. - Open-label Trial in Parkinson's Disease (PD)
AbbVie Inc. · Completed · NCT04760769 - Fixed-Dose Trial in Early Parkinson's Disease (PD)
AbbVie Inc. · Completed · NCT04201093 - Fixed-Dose Trial in Early Parkinson s Disease (PD) (TEMPO-1)
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.